Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

CENTRIENT PHARMACEUTICALS LLC

Filed by AKIN GUMP STRAUSS HAUER & FELD.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
546e4673-f790-400c-93bf-665821908a13
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

PHA · Pharmacy

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

MAN · Manufacturing

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

DEF · Defense

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States; Issues related to the Defense Production Act (P.L. 115-232).

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.